Pembrolizumab associated Stevens–Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma
Author:
Affiliation:
1. Department of Dermatology The First Affiliated Hospital of Fujian Medical University Fuzhou China
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13704
Reference10 articles.
1. Cutaneous adverse events (AEs) of anti‐programmed cell death (PD)‐1 therapy in patients with metastatic melanoma: a single‐institution cohort;Hwang SJE;J. Am. Acad. Dermatol.,2016
2. Eruptive porokeratosis during pembrolizumab treatment of invasive cutaneous squamous cell carcinoma;Maredia H;Int. J. Dermatol.,2019
3. Dermatologic reactions to immune checkpoint inhibitors;Sibaud V;Am. J. Clin. Dermatol.,2018
4. Drugs associated with development of porokeratosis: a systematic review;Lu JD;Dermatol. Ther.,2021
5. Cutaneous eruptions in patients receiving immune checkpoint blockade: clinicopathologic analysis of the non‐lichenoid histologic pattern;Kaunitz GJ;Am. J. Surg. Pathol.,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12
2. Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases;Archives of Dermatological Research;2024-05-25
3. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04
4. Immune checkpoint inhibitor‐induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications;The Journal of Dermatology;2023-11-30
5. Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction;Frontiers in Immunology;2023-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3